Home › Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma
 

Keywords :   


Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma

2015-01-23 18:05:55| Biotech - Topix.net

Progenics Pharmaceuticals, Inc., announced today that it has dosed the first subject in the resumed pivotal Phase 2 clinical study of Azedra in patients with malignant pheochromocytoma and paraganglioma. The trial is being conducted under a Special Protocol Assessment with the U.S. Food and Drug Administration .

Tags: trial pharmaceuticals pivotal relaunches

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
29.09Hurricane Isaac Graphics
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Forecast Discussion Number 14
29.09Tropical Storm Joyce Forecast Discussion Number 8
29.09Hurricane Isaac Public Advisory Number 14
29.09Summary for Hurricane Isaac (AT5/AL102024)
More »